Squamous cell carcinoma cells (SCC)

Squamous cell carcinoma (SCC) cells are malignant epithelial cells derived from the squamous epithelium, which lines various organs including the skin, respiratory tract, and digestive tract. These cells are characterized by uncontrolled proliferation, the ability to invade local tissues, and potential for metastasis to regional lymph nodes or distant organs. While not a single molecular target themselves, SCC cells serve as the pathological substrate for various targeted therapies, frequently overexpressing receptors like the Epidermal Growth Factor Receptor (EGFR). Genomic instability, particularly involving mutations in the TP53 gene, is a hallmark of these cells. Modern oncology focuses on identifying specific molecular vulnerabilities within SCC cells, such as PD-L1 expression, to utilize immunotherapy and other precision medicine approaches.

Other names

Squamous cell carcinomaSCC cellsEpidermoid carcinomaMalignant squamous cells

Targeting molecules on the cell surface such as Epidermal Growth Factor Receptor (EGFR) inhibition or Programmed Death-Ligand 1 (PD-L1) blockade to induce apoptosis or immune-mediated destruction of the malignant cells.